Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.70
-0.12 (-1.53%)
At close: Apr 28, 2026, 4:00 PM EDT
7.70
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $363.70 million as of April 28, 2026. Its market cap has increased by 251.67% in one year.
Market Cap
363.70M
Enterprise Value
278.75M
1-Year Change
251.67%
Ranking
Category
Stock Price
$7.70
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $363.70M, a decrease of -32.44%. That is a compound annual growth rate of -6.72%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 388.23M |
| Autolus Therapeutics | 387.24M |
| Puma Biotechnology | 383.61M |
| Opus Genetics | 377.72M |
| YD Bio | 374.10M |
| Armata Pharmaceuticals | 366.33M |
| Monopar Therapeutics | 361.38M |
| Ovid Therapeutics | 353.42M |